Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Weak + Overbought | Other | 1.01% | |
| Overbought Stochastic | Strength | 1.01% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% |
| Alert | Time |
|---|---|
| 10 DMA Support | 3 days ago |
| Possible Inside Day | 3 days ago |
| Possible NR7 | 3 days ago |
| Rose Above 10 DMA | 4 days ago |
| Up 1% | 4 days ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-06-06
Eupraxia Pharmaceuticals Inc Description
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pain Biotechnology Life Sciences Arthritis Osteoarthritis Skeletal Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.1 |
| 52 Week Low | 3.44 |
| Average Volume | 74,720 |
| 200-Day Moving Average | 5.843 |
| 50-Day Moving Average | 4.051 |
| 20-Day Moving Average | 3.901 |
| 10-Day Moving Average | 3.973 |
| Average True Range | 0.143 |
| RSI (14) | 50.74 |
| ADX | 13.21 |
| +DI | 27.164 |
| -DI | 19.802 |
| Chandelier Exit (Long, 3 ATRs) | 3.692 |
| Chandelier Exit (Short, 3 ATRs) | 3.868 |
| Upper Bollinger Bands | 4.138 |
| Lower Bollinger Band | 3.663 |
| Percent B (%b) | 0.71 |
| BandWidth | 12.178 |
| MACD Line | -0.033 |
| MACD Signal Line | -0.081 |
| MACD Histogram | 0.0478 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.045 | ||||
| Resistance 3 (R3) | 4.040 | 4.020 | 4.038 | ||
| Resistance 2 (R2) | 4.020 | 4.009 | 4.023 | 4.035 | |
| Resistance 1 (R1) | 4.010 | 4.001 | 4.015 | 4.015 | 4.032 |
| Pivot Point | 3.990 | 3.990 | 3.993 | 3.993 | 3.990 |
| Support 1 (S1) | 3.980 | 3.979 | 3.985 | 3.985 | 3.968 |
| Support 2 (S2) | 3.960 | 3.971 | 3.963 | 3.965 | |
| Support 3 (S3) | 3.950 | 3.960 | 3.963 | ||
| Support 4 (S4) | 3.955 |
